Aurobindo Pharma Q2 FY27 Results: Net Profit ₹1,124 Cr, Up 32.5% YoY
Aurobindo Pharma Ltd reported revenue from operations of ₹10,263 Cr (+23.9% YoY) and net profit of ₹1,124 Cr (+32.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,124 Cr · +32.5% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Aurobindo Pharma Ltd reported revenue from operations of ₹10,263 Cr (+23.9% YoY) and net profit of ₹1,124 Cr (+32.5% YoY) for Q2 FY27.
Aurobindo Pharma Ltd reported revenue from operations of ₹9,150 Cr (+16.3% YoY) and net profit of ₹1,032 Cr (+25.2% YoY) for Q1 FY27.
Aurobindo Pharma Ltd reported revenue from operations of ₹8,853 Cr (+5.6% YoY) and net profit of ₹920.8 Cr (+2.0% YoY) for Q4 FY26.
Aurobindo Pharma reported consolidated annual revenue of ₹33,653.08 Crore and profit after tax of ₹3,502.97 Crore. The results show consistent performance across its global pharmaceutical operations.